Posted in | News | Nanomedicine | Nanobusiness

New Report Examines Technologies, Markets and Competitive Environment of Drug Delivery Using Nanotechnology

Research and Markets has announced the addition of the "Drug Delivery Using Nanotechnologies: Technologies, Markets and Competitive Environment" report to their offering.

Drug delivery commands a sizeable proportion of the overall pharmaceutical market, approximately 15% or some US 109 billion in 2008. It is also expected to grow at a faster rate than the overall pharmaceutical market over the next 4 years. The reason Extending patent life for existing drugs and offering new alternatives for delivery, in particular the peroral route.

In all of this nanotechnology is a major enabler. Previously insoluble drugs can be re-packaged or formulated both increasing efficacy and decreasing the need for solvents. Greater stability can be assured by novel nanostructured materials and processes utilising nanotechnology. Such developments are not going unnoticed, with strategic collaborations, mergers and acquisitions becoming the norm.

This report, written by Tiju Joseph and Richard Moore of the Institute of Nanotechnology, provides a comprehensive overview of these new technologies and a market analysis of opportunities to 2012. It concludes with a description of over 40 emerging companies in this exciting and fast-developing field.

Companies Mentioned:

- Abraxis Biosciences Inc. - Access Pharmaceuticals Inc. - Allergan Inc. - ALZA Corporation - Aphios Corporation - Artificial Cell Technologies - Avidimer Therapeutics - Azaya Therapeutics - Baxter Healthcare - BioAlliance Pharma - Biodelivery Sciences International - Biophan - Calando Pharmaceuticals - Capsulution Nanosciences AG - Dabur Research Foundation - Elan Corporation - Endovasc - Enzon Pharmaceuticals Inc - Exilica Ltd - Flamel Technologies - Gilead Sciences, Inc - ICeutica - Insert Therapeutics - ImuThes Ltd - Intezyne Technologies - Keystone Nano - Labopharm - Magforce Nanotechnologies - Nanocarrier - Nanocopoeia - NanoBioMagnetics - Nanobiotix - Nanomerics - Nanotherapeutics - NanoViricides Inc - Neopharm - Novosom - Psividia - SamYang - Spherics - Starpharma - Skyepharma - Tekmira Pharmaceuticals Corporation - XstalBio

For more information visit http://www.researchandmarkets.com/research/683fce/drug_delivery_usin.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Research and Markets. (2019, February 15). New Report Examines Technologies, Markets and Competitive Environment of Drug Delivery Using Nanotechnology. AZoNano. Retrieved on April 18, 2024 from https://www.azonano.com/news.aspx?newsID=8440.

  • MLA

    Research and Markets. "New Report Examines Technologies, Markets and Competitive Environment of Drug Delivery Using Nanotechnology". AZoNano. 18 April 2024. <https://www.azonano.com/news.aspx?newsID=8440>.

  • Chicago

    Research and Markets. "New Report Examines Technologies, Markets and Competitive Environment of Drug Delivery Using Nanotechnology". AZoNano. https://www.azonano.com/news.aspx?newsID=8440. (accessed April 18, 2024).

  • Harvard

    Research and Markets. 2019. New Report Examines Technologies, Markets and Competitive Environment of Drug Delivery Using Nanotechnology. AZoNano, viewed 18 April 2024, https://www.azonano.com/news.aspx?newsID=8440.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.